Deals

Gingko Bioworks Raises $275M Series D Funding Valuing the Company Over $1B
Date: 
Thursday, December 14, 2017
Location: 
Boston
Categories: 
Big Data & Analytics
Healthcare & Pharma
Other
Deal Type: 
Funding

As reported by TechCrunch:

Boston biotech startup Ginkgo Bioworks has announced the raise of $275 million in Series D funding to build out its Bioworks3 production facility.

The funding comes from previous investors Viking Global, Y Combinator’s Continuity Fund, Cascade Investment, Bill Gates, as well as new investor, General Atlantic.

The company previously raised over $154 million, bringing the total up to $429 million in the three years since launching out of Y Combinator. The new raise now puts Ginkgo’s valuation at over $1 billion, according to sources... READ MORE